PetMed Express, Inc.
PETS · NASDAQ
3/31/2025 | 12/31/2024 | 9/30/2024 | 6/30/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.00 | 0.27 | -0.21 | -0.03 |
| FCF Yield | 5.35% | -1.95% | 8.08% | -11.10% |
| EV / EBITDA | -11.93 | 44.42 | 11.29 | 6.26 |
| Quality | ||||
| ROIC | -13.56% | -1.35% | 1.42% | 3.67% |
| Gross Margin | 40.77% | 28.14% | 29.06% | 23.91% |
| Cash Conversion Ratio | -0.60 | 1.65 | 3.18 | -2.27 |
| Growth | ||||
| Revenue 3-Year CAGR | -4.04% | -1.75% | -0.38% | 0.81% |
| Free Cash Flow Growth | 337.98% | -131.73% | 166.57% | -256.60% |
| Safety | ||||
| Net Debt / EBITDA | 19.56 | -43.13 | -22.98 | -7.31 |
| Interest Coverage | -48.94 | 0.00 | 0.00 | 0.00 |
| Efficiency | ||||
| Inventory Turnover | 1.70 | 3.23 | 3.23 | 2.03 |
| Cash Conversion Cycle | -19.58 | 5.85 | -5.77 | 4.83 |